Anticoagulants and osteoporosis;Anticoagulants et risque d'ostéoporose

Revue Medicale Suisse

Volumn 3, Issue 115, 2007, Pages 1508-1511

  Ferrière, Karine ^a   Rizzoli, René ^a  

^a HUG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CALCIUM; CARBOXYLIC ACID DERIVATIVE; CORTICOSTEROID; DALTEPARIN; DICOUMAROL; ENOXAPARIN; ERGOCALCIFEROL; FLUINDIONE; HEPARIN; PLACEBO; PROTON PUMP INHIBITOR; VITAMIN K GROUP; WARFARIN;

ANTICOAGULATION; CLINICAL TRIAL; FRACTURE; HUMAN; MEDICAL LITERATURE; OSTEOPOROSIS; REVIEW; RISK FACTOR; THROMBOEMBOLISM; TREATMENT INDICATION;

ANTICOAGULANTS; BONE DENSITY; FRACTURES, BONE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; OSTEOPOROSIS; RISK FACTORS;

EID: 34347382358     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Meyer B, Jende C, Rikli D, et al. Conduits périopératoire de l'anticoagulation orale: exemples de situations et recommandations. Forum Medical Suisse 2003; 9:213-8.
2. Dahlmann TC. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol 1993; 168:1265-70.
3. Squires JW, Pinch LW. Heparin-induced spinal fractures. JAMA 1979;241:2417-8.
4. Barbour LA, Kick SD, Steiner JF, et al. A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry. Am J Obstet Gynecol 1994; 170:862-9.
5. Douketis JD, Ginsberg JS, Burrows RF, et al. The effects of long-term heparin therapy during pregnancy on bone density. A prospective matched cohort study. Thromb Haemost 1996;75:254-7.
6. Shefras J, Farquharson RG. Bone density studies in pregnant women receiving heparin. Eur J Obstet Gynecol Reprod Biol 1996;65:171-4.
7. Nelson-Piercy C, Letsky EA, de Swiet M. Low-molecular-weight heparin for obstetric thromboprophylaxis: Experience of sixty-nine pregnancies in sixty-one women at high risk Am J Obstet Gynecol 1997;176: 1062-8.
8. Casele HL, Laifer SA. Prospective evaluation of bone density in pregnant women receiving the low molecular weight heparin enoxaparin sodium. J Matern Fetal Med 2000;9:122-5.
9. Carlin AJ, Farquharson RG, Quenby SM, Topping J, Fraser WD. Prospective observational study of bone mineral density during pregnancy: Low molecular weight heparin versus control. Hum Reprod 2004;19:1211-4.
10. Backos M, Rai R, Thomas E, et al. Bone density changes in pregnant women treated with heparin: A prospective, longitudinal study. Hum Reprod 1999;14: 2876-80.
11. * Jamal SA, Browner WS, Bauer DC, Cummings SR. Warfarine use and risk for osteoporosis in elderly women. Ann Intern Med 1998;128:829-32.
12. Mamdani M, Upshur RE, Anderson G, Bartle BR, Laupacis A. Warfarin therapy and risk of hip fracture among elderly patients. Pharmacotherapy 2003;23:1-4.
13. Pilon D, Castilloux AM, Dorais M, Le Lorier J. Oral anticoagulans and the risk of osteoporotic fractures among elderly. Pharmacoepidemiol Drug Saf 2004;13: 289-94.
14. Gage BF, Birman-Deych E, Radford MJ, Nilasena DS, Binder EF. Risk of osteoporotic fracture in elderly patients taking warfarin: Results from the National Registry of Atrial Fibrillation 2. Arch Intern Med 2006;166: 241-6.
15. * Caraballo PJ, Heit JA, Atkinson EJ, et al. Long-term use of oral anticoagulants and the risk of fracture. Arch Intern Med 1999;159:1750-6.